PHOTOCURE: VISONAC® PHASE 2b TRIAL RESULTS - INVITATION TO PRESENTATION AND WEBCAST

Oslo, Norway, May 31, 2012 : Photocure ASA (OSE: PHO), is pleased to announce the results of its Phase 2b study for Visonac, a novel topical treatment under development for moderate to severe acne. Photocure will host a presentation and webcast at 15.00 CET / 14.00 BST / 09.00 EST to present the results on Thursday 31 st May 2012. WHERE : Hotel Continental, Stortingsgaten 24/26, Oslo, Norway SPEAKERS: Kjetil Hestdal, President & CEO, Photocure Dr. David Pariser, MD, Principal Investigator Grete Hogstad, Vice President Strategic Marketing, Photocure Inger Ferner Heglund, VP Research & Development, Photocure You can access the webcast and presentation via www.photocure.com or directly through: http://webtv.hegnar.no/webcast.php?id=65542 . For a replay of the webcast please go to www.photocure.com . For further information, please contact: Photocure President & CEO Kjetil Hestdal Tel: + 47 913 19 535, Email: [email protected] M: Communications Mary Clark, Amber Bielecka, Hollie Vile Tel: +44 207920 2361, Email: [email protected] This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

The release as fetched from its publisher. photocure.com ↗